OSE Immunotherapeutics SA (FRA:6OP)

OSE Immunotherapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	118	157	81	123	188	129
Market Cap Growth	-37.24%	94.71%	-34.73%	-34.26%	45.49%	133.63%
Enterprise Value	106	125	109	128	184	126
Last Close Price	5.25	7.21	4.28	6.58	10.32	6.90
PE Ratio	3.16	4.19	-	-	-	-
PS Ratio	1.42	1.88	36.17	6.74	7.14	12.38
PB Ratio	1.86	2.46	3.51	3.78	3.92	2.10
P/TBV Ratio	1.86	2.46	3.53	3.80	3.93	2.10
P/FCF Ratio	2.45	3.24	-	-	-	-
P/OCF Ratio	2.45	3.24	-	-	-	-
EV/Sales Ratio	1.26	1.50	49.07	6.99	7.01	12.09
EV/EBITDA Ratio	2.36	2.84	-	-	-	-
EV/EBIT Ratio	2.41	2.86	-	-	-	-
EV/FCF Ratio	2.18	2.58	-	-	-	-
Debt / Equity Ratio	0.72	0.72	1.99	1.37	0.78	0.32
Debt / EBITDA Ratio	1.03	1.03	-	-	-	-
Debt / FCF Ratio	0.95	0.95	-	-	-	-
Asset Turnover	0.81	0.81	0.03	0.19	0.27	0.11
Quick Ratio	3.29	3.29	1.40	1.97	2.36	2.57
Current Ratio	3.46	3.46	1.62	2.29	2.64	2.82
Return on Equity (ROE)	86.29%	86.29%	-82.69%	-44.10%	-30.85%	-27.62%
Return on Assets (ROA)	26.54%	26.54%	-16.53%	-11.93%	-10.45%	-12.77%
Return on Capital (ROIC)	30.59%	30.59%	-19.65%	-14.21%	-12.53%	-15.73%
Return on Capital Employed (ROCE)	42.20%	42.20%	-36.30%	-24.50%	-19.50%	-22.90%
Earnings Yield	31.60%	23.88%	-28.56%	-14.39%	-8.98%	-12.83%
FCF Yield	40.81%	30.84%	-24.56%	-15.01%	-5.54%	-15.32%
Buyback Yield / Dilution	-31.11%	-31.11%	-5.58%	-2.05%	-16.71%	-4.46%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.